Genetic Polymorphisms of Multidrug Resistance Gene-1 (MDR1/ABCB1) and Glutathione S-Transferase Gene and the Risk of Inflammatory Bowel Disease among Moroccan Patients
Autor: | Nezha Senhaji, Yaya Kassogue, Mina Fahimi, Nadia Serbati, Wafaa Badre, Sellama Nadifi |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2015 |
Předmět: | |
Zdroj: | Mediators of Inflammation, Vol 2015 (2015) |
Druh dokumentu: | article |
ISSN: | 0962-9351 1466-1861 |
DOI: | 10.1155/2015/248060 |
Popis: | Inflammatory bowel diseases (IBD) are multifactorial disorders resulting from environmental and genetic factors. Polymorphisms in MDR1 and GSTs genes might explain individual differences in susceptibility to IBD. We carried out a case-control study to examine the association of MDR1 (C1236T and C3435T), GSTT1, and GSTM1 polymorphisms with the risk of IBD. Subjects were genotyped using PCR-RFLP for MDR1 gene and multiplex PCR for GSTT1 and GSTM1. Meta-analysis was performed to test the association of variant allele carriage with IBD risk. We report that GSTT1 null genotype is significantly associated with the risk of CD (OR: 2.5, CI: 1.2–5, P=0.013) and UC (OR: 3.5, CI: 1.5–8.5, P=0.004) and can influence Crohn’s disease behavior. The interaction between GSTT1 and GSTM1 genes showed that the combined null genotypes were associated with the risk of UC (OR: 3.1, CI: 1.1–9, P=0.049). Furthermore, when compared to combined 1236CC/CT genotypes, the 1236TT genotype of MDR1 gene was associated with the risk of UC (OR: 3.7, CI: 1.3–10.7, P=0.03). Meta-analysis demonstrated significantly higher frequencies of 3435T carriage in IBD patients. Our results show that GSTT1 null and MDR1 polymorphisms could play a role in susceptibility to IBD. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |